![Vikram Karnani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vikram Karnani
Vorstandsvorsitzender bei
COLLEGIUM PHARMACEUTICAL, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Vikram Karnani is President, Chief Executive Officer & Director at Collegium Pharmaceutical, Inc. since 2024.
Mr. Karnani is Independent Director at Dyne Therapeutics, Inc. starting in 2025.
Formerly, Mr. Karnani was VP-Therapeutics & Cell Therapy Business at Fresenius Kabi USA LLC from 2011 to 2014.
Mr. Karnani was Chief Commercial Officer & Executive VP at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020.
Mr. Karnani was President-Commercial Operations & Medical Affairs at Amgen, Inc. Education includes graduate studies at Case Western Reserve University, undergraduate studies at the University of Mumbai, and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 39’121 ( 0.12% ) | 1 Mio $ | 31.05.2026 | |
| 01.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktuelle Nachrichten zu Vikram Karnani
Aktive Positionen von Vikram Karnani
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Vorstandsvorsitzender | 12.11.2024 |
| DYNE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 22.12.2025 |
Ehemalige bekannte Positionen von Vikram Karnani
| Unternehmen | Position | Ende |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2023 |
Fresenius Kabi USA LLC
 Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Provides healthcare products and services | Corporate Officer/Principal | 01.08.2014 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Vikram Karnani
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fresenius Kabi USA LLC
Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Provides healthcare products and services | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
